Survodutide Peptide 12mg Multi-Dose Vial for Laboratory Research

Survodutide is a dual-agonist peptide that binds both GLP-1 (glucagon-like peptide-1) and glucagon receptors, placing it in the incretin class of research compounds. It was originally developed by Boehringer Ingelheim as an investigational compound.

Its two-receptor mechanism is of research interest because it engages incretin signaling and glucagon signaling simultaneously, a profile that differs from single-target GLP-1 analogues. Published preclinical and early clinical literature has examined its activity across metabolic, hepatic, and energy-expenditure pathways.

Real Peptides supplies Survodutide as a laboratory research reagent. It is not a drug, is not approved for any therapeutic use, and is not for human or veterinary administration.

Survodutide appears in published research examining incretin biology, hepatic lipid metabolism, and receptor pharmacology. Points of research interest include:

• Dual mechanism of action: Simultaneous GLP-1 and glucagon receptor engagement, studied for pathway interaction effects.
• Investigational status: Survodutide remains an investigational compound and is not FDA-approved, making it a subject of active early-stage literature.
• Hepatic pathway activity: Preclinical data examining hepatic lipid handling in animal models.
• Receptor comparison studies: Frequently referenced in comparative work against other incretin-class compounds.
• Co-study designs: Appears in research designs alongside other metabolic-pathway compounds.

For Research Use Only. Not for human or veterinary use.

Survodutide differs from single-target incretin compounds through its glucagon receptor activity, which introduces a second signaling pathway. In published comparative literature, points of distinction studied include:

• Glucagon receptor engagement in addition to GLP-1 binding
• Hepatic lipid pathway activity in preclinical models
• Substrate utilization pathways examined alongside receptor-mediated signaling
• Distinct pharmacokinetic profile relative to other incretin-class compounds

Real Peptides supplies Survodutide with third-party HPLC verification and per-lot COAs.